Inj. Benralizumab 30 Mg (Brand - Inj. Fasenra 30 Mg, Marketed by M/S Astrazeneca... Tender

Procurement Summary

State : Uttar Pradesh

Summary : Inj. Benralizumab 30 Mg (Brand - Inj. Fasenra 30 Mg, Marketed by M/S Astrazeneca Pharma India Limited) Per Unit

Deadline : 27 Jun 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 102307312

Document Ref. No. : 82245251

Competition : NCB

Financier : Self Financed

Purchaser Ownership : Public

Document Fees : Refer Document

Tender Value : Refer Document

EMD : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Inj. Benralizumab 30 Mg (Brand - Inj. Fasenra 30 Mg, Marketed by M/S Astraze Neca Pharma India Limited) Per Unit (Item No.2359 of Ami 2024-25). (Item to be Supplied in 3 Parts. 1St Part Within One Month of Po Generation, 2Nd & 3Rd Part as Per Demanded B Y Consignee. and Bill to be Raised Accordingly)
Contract Category: Expenditure
Contract Type : Goods
Tender Type : PAC - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : 82
Inspection Agency : CONSIGNEE
Publishing Date / Time : 07/06/2024 14:40
Procure From Approved Sources : No
Approving Agency : Not Applicable
Closing Date Time : 27/06/2024 10:55
Validity of Offer ( Days) : 120
Ranking Order for Bids : Lowest to Highest
Advertised Value :
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 0.00

Consignee CMS/JHS, NCR Uttar Pradesh 3.00 Numbers

Documents

 Tender Notice

viewNitPdf_4598762.pdf

4954794.pdf